115 related articles for article (PubMed ID: 34579917)
1. Heparin-like anticoagulant polypeptides with tunable activity: Synthesis, characterization, anticoagulative properties and clot solubilities in vitro.
Lu D; Jin Y; Wang X; Xie L; Liu Q; Chen Y; Wang H; Lei Z
Mater Sci Eng C Mater Biol Appl; 2021 Oct; 129():112405. PubMed ID: 34579917
[TBL] [Abstract][Full Text] [Related]
2. Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane.
Han DK; Lee NY; Park KD; Kim YH; Cho HI; Min BG
Biomaterials; 1995 Apr; 16(6):467-71. PubMed ID: 7654873
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant Heparin Mimetics via RAFT Polymerization.
Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Vamvounis G; Ferro V
Biomacromolecules; 2020 Feb; 21(2):1009-1021. PubMed ID: 31841320
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
Wang ZM; Li L; Li B; Guo SY
Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
[TBL] [Abstract][Full Text] [Related]
5. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulant effects of inhaled unfractionated heparin in the dog as determined by partial thromboplastin time and factor Xa activity.
Manion JS; Thomason JM; Langston VC; Claude AK; Brooks MB; Mackin AJ; Lunsford KV
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):132-6. PubMed ID: 26194053
[TBL] [Abstract][Full Text] [Related]
8. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
Tanaka KA; Szlam F; Rusconi CP; Levy JH
Thromb Haemost; 2009 May; 101(5):827-33. PubMed ID: 19404534
[TBL] [Abstract][Full Text] [Related]
9. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time.
Nielsen VG
Anesth Analg; 2002 Dec; 95(6):1503-6, table of contents. PubMed ID: 12456408
[TBL] [Abstract][Full Text] [Related]
10. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant and antiprotease activities of aprosulate sodium, a new synthetic polyanion, in human plasma and purified systems.
Sugidachi A; Asai F; Koike H
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):773-9. PubMed ID: 7865684
[TBL] [Abstract][Full Text] [Related]
12. Laboratory assays for the evaluation of recombinant hirudin.
Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
[TBL] [Abstract][Full Text] [Related]
13. Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests.
Tobu M; Iqbal O; Hoppensteadt DA; Shultz C; Jeske W; Fareed J
Clin Appl Thromb Hemost; 2002 Oct; 8(4):325-36. PubMed ID: 12516682
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.
Wall D; Douglas S; Ferro V; Cowden W; Parish C
Thromb Res; 2001 Aug; 103(4):325-35. PubMed ID: 11562342
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides.
Lee SH; Lee W; Bae JS; Ma E
Molecules; 2016 May; 21(5):. PubMed ID: 27213328
[TBL] [Abstract][Full Text] [Related]
16. Intersubject variability in the anticoagulant response to heparin in vitro.
Bjornsson TD; Wolfram KM
Eur J Clin Pharmacol; 1982; 21(6):491-7. PubMed ID: 6176454
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum.
Matsubara K; Matsuura Y; Bacic A; Liao M; Hori K; Miyazawa K
Int J Biol Macromol; 2001 Jun; 28(5):395-9. PubMed ID: 11325427
[TBL] [Abstract][Full Text] [Related]
18. The APTT response of pregnant plasma to unfractionated heparin.
Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
[TBL] [Abstract][Full Text] [Related]
19. Phosphotungstate shows a heparin-like anticoagulant effect but inhibits heparin.
Tajima Y; Amagai H; Okamura N
Thromb Res; 1989 Aug; 55(3):329-39. PubMed ID: 2781532
[TBL] [Abstract][Full Text] [Related]
20. The aPTT assay as a monitor of heparin anticoagulation efficacy in clinical settings.
Chen CC; You JY; Ho CH
Adv Ther; 2003; 20(5):231-6. PubMed ID: 14964342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
